Recruiting studies: Total Body Irradiation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

TLI, TBI, ATG & Hematopoietic Stem Cell Transplantation and Recipient T Regs Therapy in Living Donor Kidney Transplantat
Phase 1 · 2 location(s) · Stanford University · NCT03943238 Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation
Phase N/A · 1 location(s) · Northside Hospital, Inc. · NCT05417971 Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies
Phase 2 · 3 location(s) · Hackensack Meridian Health · NCT07214688 TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT
NA · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT06125483 Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant
Phase 1/Phase 2 · 1 location(s) · Fred Hutchinson Cancer Center · NCT06928662 Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients
Phase 2 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07400328 HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib
Phase 2 · 1 location(s) · Henry Ford Health System · NCT03850366 Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases
Phase 1/Phase 2 · 1 location(s) · Fred Hutchinson Cancer Center · NCT04083183 Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hem
Phase 2 · 1 location(s) · Fred Hutchinson Cancer Center · NCT07046078 Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00106925 Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Re
Phase 1/Phase 2 · 1 location(s) · Fred Hutchinson Cancer Center · NCT07225985 The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults
Phase 2 · 24 location(s) · Pediatric Transplantation & Cellular Therapy Consortium · NCT03509961 Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological M
Phase 2 · 1 location(s) · Fred Hutchinson Cancer Center · NCT04195633 Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patient
NA · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT06803745 TBI Using IMRT and Cyclophosphamide Prior to Stem Cell Transplant for the Treatment of Severe Systemic Sclerosis
EARLY_Phase 1 · 1 location(s) · City of Hope Medical Center · NCT04380831 A Single-arm, Prospective Study of TBI + BUMEL As a Conditioning Regimen for Salvage HSCT in Patients with R/R AML
NA · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT06879847 Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant
Phase 1 · 1 location(s) · Ronald Paquette · NCT05849207 Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marr
Phase 1/Phase 2 · 2 location(s) · National Cancer Institute (NCI) · NCT04959175 Total Neoadjuvant Treatment of Rectal Cancer by MRI-guided Radiotherapy
Phase N/A · 1 location(s) · Universitair Ziekenhuis Brussel · NCT05916040 Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hem
Phase 2 · 1 location(s) · Fred Hutchinson Cancer Center · NCT06013423 A Single-Arm, Prospective Study of TBI+BUMEL as Conditioning for SCT2 in Patients With Malignant Hematologic Diseases
NA · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT06548958 Chlorophyllin for Reducing Oral Mucositis in Total Body Irradiation Prior to Transplant
Phase 2 · 1 location(s) · Tata Memorial Centre · NCT07709195 Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation
Phase 1/Phase 2 · 1 location(s) · Vanderbilt-Ingram Cancer Center · NCT06110572 Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-c
Phase 1 · 1 location(s) · Washington University School of Medicine · NCT06623630 Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer
Phase N/A · 1 location(s) · Affidea Nu-med Center of Oncological DIagnostics and Therapy · NCT07667192

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.